Similar Search Results

Análisis económico de los comportamientos adictivos no saludables: principales propuestas teóricas

Portillo Pérez de Viñaspre, Fabiola; Antoñanzas … - 2001

Persistent link: https://www.econbiz.de/10001607790

Análisis de la información existente en España sobre los riesgos asociados al consumo de tabaco: una aplicación del modelo bayesiano

Portillo Pérez de Viñaspre, Fabiola; Antoñanzas … - In: Información comercial española : ICE : revista de … (2003), pp. 169-184

Persistent link: https://www.econbiz.de/10001761024

Hábitos no saludables y desempleo

Portillo Pérez de Viñaspre, Fabiola; Antoñanzas … - In: Cuadernos aragoneses de economía 12 (2002) 2, pp. 257-270

Persistent link: https://www.econbiz.de/10001947276

La reforma del sistema sanitario

Antoñanzas Villar, Fernando (contributor); … - 1992

Persistent link: https://www.econbiz.de/10000856467

Costes directos e indirectos del cáncer en España

Antoñanzas Villar, Fernando; Oliva, Juan; Velasco, María - In: Información comercial española / Cuadernos económicos 72 (2006), pp. 281-309

Persistent link: https://www.econbiz.de/10003464193

Spanish recommendations on economic evaluation of health technologies

López-Bastida, Julio; Oliva, Juan; Antoñanzas Villar, … - In: The European journal of health economics : HEPAC ; … 11 (2010) 5, pp. 513-520

Persistent link: https://www.econbiz.de/10008662723

Economic aspects of the new Spanish laws on pharmaceutical preparations

Antoñanzas Villar, Fernando; Oliva, Juan; Pinillos … - In: The European journal of health economics : HEPAC ; … 8 (2007) 3, pp. 297-300

Persistent link: https://www.econbiz.de/10003546677

Feeding the economics of obesity in the EU in a healthy way

Antoñanzas Villar, Fernando; Rodríguez, Roberto - In: The European journal of health economics : HEPAC ; … 11 (2010) 4, pp. 351-353

Persistent link: https://www.econbiz.de/10003987307

Innovation, loyalty and generic competition in pharmaceutical markets

Antoñanzas Villar, Fernando; Juárez-Castelló, Carmelo; … - In: SERIEs : Journal of the Spanish Economic Association 2 (2011) 1, pp. 75-95

We analyze how a manufacturer with a brand-name drug close to patent expiration decides to launch a product-line extension (an upgrade through innovation) before it faces generic competition. There are two types of physicians: loyal physicians always prescribe first the product-line extension...

Persistent link: https://www.econbiz.de/10009355566

Should health authorities offer risk-sharing contracts to pharmaceutical firms? : a theoretical approach

Antoñanzas Villar, Fernando; Juarez-Castello, Carmelo; … - In: Health economics, policy and law 6 (2011) 3, pp. 391-403

Persistent link: https://www.econbiz.de/10009247147